Minimize Uncertainty – Make Informed Decisions – Succeed

Obesity Weekly News

Obesity Today—December 16, 2025

December 16, 2025wegovy,semaglutide,BioPharma and Tech News,Novo Nordisk,Zepbound,Eli Lilly,GLP-1 receptor agonist,oral GLP-1,Obesity Newstriple agonist,retatrutide

Explore this week’s obesity highlights, including new developments, pipeline…

by LucidQuest

Endocrinology

Endocrinology Today—December 16, 2025

December 16, 2025semaglutide,BioPharma and Tech News,Tirzepatide,type 2 diabetes,Insulin Resistance,GLP-1 Receptor Agonists,Endocrinology News,gut microbiome,Continuous Glucose MonitoringChronic inflammation,ADA Standards of Care

Catch up on this week’s endocrinology highlights—from major developments and…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Chai Discovery $130M Series B

December 16, 2025Oncology,biopharma,Lucid Diligence Brief,diligence,venture funding,platform biotech,AI drug discovery,partnerships,antibody design,molecular design,cryo-EMGPCR

Lucid Diligence Brief: Chai Discovery $130M Series B Professional audiences…

by Timos Papagatsias

Onco_background

Oncology Today—December 15, 2025

December 15, 2025roche,prostate cancer,BioPharma and Tech News,Ovarian Cancer,Eli Lilly,Oncology News,antibody-drug conjugates,Non-small cell lung cancer,Triple-negative breast cancermetastatic uveal melanoma,ER-positive breast cancer

This week’s oncology update spotlights key developments, regulatory milestones,…

by LucidQuest

Hematology

Hematology Video Recap—December 15, 2025

December 15, 2025hemophilia,Multiple Myeloma,BioPharma and Tech News,Marginal Zone Lymphoma,Acute Myeloid Leukemia,Hematology News,chronic lymphocytic leukemia,Senti Bio,NMPA China,Small lymphocytic lymphoma,Myelofibrosis related anemiaClassical Hodgkin lymphoma,Thrombotic thrombocytopenic purpura

This biweekly hematology update covers major regulatory decisions, late-stage…

by LucidQuest

Hematology

Hematology Today—December 15, 2025

December 15, 2025hemophilia,gene therapy,novartis,Bispecific Antibodies,Multiple Myeloma,BioPharma and Tech News,Johnson & Johnson,Acute Myeloid Leukemia,Hematology News,chronic lymphocytic leukemiaImmune thrombocytopenia,CAR-NK therapy

This week’s hematology update spotlights key developments, regulatory…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—December 15, 2025

December 15, 2025Oncotype DX,Hims and Hers,Google,Tether QVAC Health,ASCO,Doctronic,BioPharma and Tech News,Gosta Labs,Parkinson's Disease,OMRON Healthcare,WHO,Heartnote,sleep AI,Tricog,Microsoft,HSA,Paroxysmal Nocturnal Hemoglobinuria,Shanghai Mental Health Center,MHRA,Lingxi,AI in Healthcare and Digital Health,Respiree,Metabolic dysfunction associated steatohepatitis,Science Corp,SABCS,BMJ,Atropos HealthEU antitrust authority,ICM+

This AI in Healthcare and Digital Health update highlights the biggest…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Impulse Dynamics $158m financing

December 15, 2025clinical trials,reimbursement,FDA,HEART FAILURE,medtech,Lucid Diligence Brief,payer access,diligence,CMS,implantable devicescommercialization

Lucid Diligence Brief: Impulse Dynamics $158m financing Professional audiences…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates

December 14, 2025clinical trials,market access,obesity,GLP-1,biopharma,IND,CMC,Lucid Diligence Brief,metabolic disease,diligence,venture financing,drug deliverycontrolled release

Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal

December 13, 2025clinical trials,market access,nephrology,Regulatory,China Pharma,biopharma,licensing,Lucid Diligence Brief,diligence,AI drug discoveryCKD anemia

Lucid Diligence Brief: Insilico-TaiGen CKD anemia licensing deal Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal

December 12, 2025clinical trials,market access,Regulatory,obesity,GLP-1,biopharma,Lucid Diligence Brief,payer access,diligence,oral therapies,China riskcombinations

Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…

by Timos Papagatsias

Vaccines_News

Vaccines Video Recap—December 12, 2025

December 12, 2025Peptinov,CDSCO,BioPharma and Tech News,NIHR Southampton,DEMENTIA,Mild cognitive impairment,Osteoarthritis,Influenza A,WHO,Osivax,shingles,Pneumococcal Disease,GC Biopharma,Vaccine news,anthrax,pertussis,Datar Cancer GeneticsVaxcyte,KDCA

This biweekly Vaccines video recap highlights covers regulatory/policy…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.